ClinicalTrials.Veeva

Menu

Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital

C

Centre Hospitalier de Gonesse

Status

Active, not recruiting

Conditions

Cerebral Infarction
Ischemic Attack, Transient
Stroke
Treatment Outcome
Thrombolytic Therapy

Study type

Observational

Funder types

Other

Identifiers

NCT07018167
0107_NEUROLOGIE

Details and patient eligibility

About

This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.

Enrollment

61 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or older
  • Confirmed diagnosis of acute ischemic stroke on imaging
  • Initial acute stroke care provided at Gonesse Hospital during the study period (3 months)
  • Intravenous thrombolysis (r-tPA) initiated at the hospital
  • Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)

Exclusion criteria

  • Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH)
  • Thrombolysis initiated before hospital arrival
  • Missing, incomplete, or unusable timing data for DNT calculation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems